LittleT, That’s great news. This company is too good to let slip out of big pharma s’ grasp. It’s not that often a revolutionary drug comes along. Plenty of drugs that improve outcomes but this is first ever treatment for so many indications.
They just won’t sit in the back stalls watching . They will want control ASAP
NEU Price at posting:
$9.27 Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)